These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 37175668)

  • 1. Development of Erf-Mediated Craniosynostosis and Pharmacological Amelioration.
    Vogiatzi A; Keklikoglou K; Makris K; Argyrou DS; Zacharopoulos A; Sotiropoulou V; Parthenios N; Gkikas A; Kokkori M; Richardson MSW; Fenwick AL; Archontidi S; Arvanitidis C; Robertson J; Parthenios J; Zacharakis G; Twigg SRF; Wilkie AOM; Mavrothalassitis G
    Int J Mol Sci; 2023 Apr; 24(9):. PubMed ID: 37175668
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Erf Affects Commitment and Differentiation of Osteoprogenitor Cells in Cranial Sutures via the Retinoic Acid Pathway.
    Vogiatzi A; Baltsavia I; Dialynas E; Theodorou V; Zhou Y; Deligianni E; Iliopoulos I; Wilkie AOM; Twigg SRF; Mavrothalassitis G
    Mol Cell Biol; 2021 Jul; 41(8):e0014921. PubMed ID: 33972395
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ERF-related craniosynostosis: The phenotypic and developmental profile of a new craniosynostosis syndrome.
    Glass GE; O'Hara J; Canham N; Cilliers D; Dunaway D; Fenwick AL; Jeelani NO; Johnson D; Lester T; Lord H; Morton JEV; Nishikawa H; Noons P; Schwiebert K; Shipster C; Taylor-Beadling A; Twigg SRF; Vasudevan P; Wall SA; Wilkie AOM; Wilson LC
    Am J Med Genet A; 2019 Apr; 179(4):615-627. PubMed ID: 30758909
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reduced dosage of ERF causes complex craniosynostosis in humans and mice and links ERK1/2 signaling to regulation of osteogenesis.
    Twigg SR; Vorgia E; McGowan SJ; Peraki I; Fenwick AL; Sharma VP; Allegra M; Zaragkoulias A; Sadighi Akha E; Knight SJ; Lord H; Lester T; Izatt L; Lampe AK; Mohammed SN; Stewart FJ; Verloes A; Wilson LC; Healy C; Sharpe PT; Hammond P; Hughes J; Taylor S; Johnson D; Wall SA; Mavrothalassitis G; Wilkie AO
    Nat Genet; 2013 Mar; 45(3):308-13. PubMed ID: 23354439
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Noonan syndrome-like phenotype in a patient with heterozygous ERF truncating variant.
    Yamada M; Funato M; Kondo G; Suzuki H; Uehara T; Takenouchi T; Sakamoto Y; Kosaki K
    Congenit Anom (Kyoto); 2021 Nov; 61(6):226-230. PubMed ID: 34184330
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ERF: an ETS domain protein with strong transcriptional repressor activity, can suppress ets-associated tumorigenesis and is regulated by phosphorylation during cell cycle and mitogenic stimulation.
    Sgouras DN; Athanasiou MA; Beal GJ; Fisher RJ; Blair DG; Mavrothalassitis GJ
    EMBO J; 1995 Oct; 14(19):4781-93. PubMed ID: 7588608
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Heterozygous mutations in ERF cause syndromic craniosynostosis with multiple suture involvement.
    Chaudhry A; Sabatini P; Han L; Ray PN; Forrest C; Bowdin S
    Am J Med Genet A; 2015 Nov; 167A(11):2544-7. PubMed ID: 26097063
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ERF nuclear shuttling, a continuous monitor of Erk activity that links it to cell cycle progression.
    Le Gallic L; Virgilio L; Cohen P; Biteau B; Mavrothalassitis G
    Mol Cell Biol; 2004 Feb; 24(3):1206-18. PubMed ID: 14729966
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Deletion of
    Singh R; Cohen ASA; Poulton C; Hjortshøj TD; Akahira-Azuma M; Mendiratta G; Khan WA; Azmanov DN; Woodward KJ; Kirchhoff M; Shi L; Edelmann L; Baynam G; Scott SA; Jabs EW
    Cold Spring Harb Mol Case Stud; 2021 Jun; 7(3):. PubMed ID: 34117072
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ERF-related craniosynostosis and surgical management in the paediatric cohort.
    Afshari FT; Gallo P; Shafi A; Grant J; Drew A; Noons P; Jagadeesan J; Evans M; Brittain H; Rodrigues D
    Childs Nerv Syst; 2023 Apr; 39(4):983-988. PubMed ID: 36209295
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The RAS-dependent ERF control of cell proliferation and differentiation is mediated by c-Myc repression.
    Verykokakis M; Papadaki C; Vorgia E; Le Gallic L; Mavrothalassitis G
    J Biol Chem; 2007 Oct; 282(41):30285-94. PubMed ID: 17699159
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Primary Delayed Onset Craniosynostosis in a Child With ERF-Related Craniosynostosis Syndrome and Familial Cerebral Cavernous Malformation Syndrome.
    Radu S; Jedrzejewski B; Urbinelli L
    Cleft Palate Craniofac J; 2023 Oct; 60(10):1321-1325. PubMed ID: 35313736
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Severe craniosynostosis with Noonan syndrome phenotype associated with SHOC2 mutation: clinical evidence of crosslink between FGFR and RAS signaling pathways.
    Takenouchi T; Sakamoto Y; Miwa T; Torii C; Kosaki R; Kishi K; Takahashi T; Kosaki K
    Am J Med Genet A; 2014 Nov; 164A(11):2869-72. PubMed ID: 25123707
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Suppression of Fgf2 by ETS2 repressor factor (ERF) is required for chorionic trophoblast differentiation.
    Vorgia E; Zaragkoulias A; Peraki I; Mavrothalassitis G
    Mol Reprod Dev; 2017 Apr; 84(4):286-295. PubMed ID: 28244611
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A progressive and complex clinical course in two family members with ERF-related craniosynostosis: a case report.
    Körberg I; Nowinski D; Bondeson ML; Melin M; Kölby L; Stattin EL
    BMC Med Genet; 2020 May; 21(1):90. PubMed ID: 32370745
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [An infant with premature closure of cranial sutures due to variant of ERF gene and a literature review].
    Wang J; Wang D; Zeng L; Wang S
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2023 Aug; 40(8):1009-1014. PubMed ID: 37532503
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Loss-of-function variants in ERF are associated with a Noonan syndrome-like phenotype with or without craniosynostosis.
    Dentici ML; Niceta M; Lepri FR; Mancini C; Priolo M; Bonnard AA; Cappelletti C; Leoni C; Ciolfi A; Pizzi S; Cordeddu V; Rossi C; Ferilli M; Mucciolo M; Colona VL; Fauth C; Bellini M; Biasucci G; Sinibaldi L; Briuglia S; Gazzin A; Carli D; Memo L; Trevisson E; Schiavariello C; Luca M; Novelli A; Michot C; Sweertvaegher A; Germanaud D; Scarano E; De Luca A; Zampino G; Zenker M; Mussa A; Dallapiccola B; Cavé H; Digilio MC; Tartaglia M
    Eur J Hum Genet; 2024 Jun; ():. PubMed ID: 38824261
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transcriptional repressor ERF is a Ras/mitogen-activated protein kinase target that regulates cellular proliferation.
    Le Gallic L; Sgouras D; Beal G; Mavrothalassitis G
    Mol Cell Biol; 1999 Jun; 19(6):4121-33. PubMed ID: 10330152
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ERF, an ETS-related transcriptional repressor, can induce erythroid differentiation.
    Athanasiou M; Blair DG; Mavrothalassitis G
    Anticancer Res; 2003; 23(3A):2143-53. PubMed ID: 12894589
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intrafamilial variability in six family members with ERF-related craniosynostosis syndrome type 4.
    Moddemann MK; Kieslich M; Koenig R
    Am J Med Genet A; 2022 Oct; 188(10):2969-2975. PubMed ID: 35852485
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.